208 related articles for article (PubMed ID: 31919387)
1. Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity.
Bhambri A; Pinto A; Pillai B
Cell Death Dis; 2020 Jan; 11(1):3. PubMed ID: 31919387
[TBL] [Abstract][Full Text] [Related]
2. microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells.
Roshan R; Choudhary A; Bhambri A; Bakshi B; Ghosh T; Pillai B
J Neuroinflammation; 2017 Aug; 14(1):155. PubMed ID: 28774347
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.
Friedman MJ; Wang CE; Li XJ; Li S
J Biol Chem; 2008 Mar; 283(13):8283-90. PubMed ID: 18218637
[TBL] [Abstract][Full Text] [Related]
5. Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila.
Shieh SY; Bonini NM
Hum Mol Genet; 2011 Dec; 20(24):4810-21. PubMed ID: 21933837
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S
Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914
[TBL] [Abstract][Full Text] [Related]
7. Spinocerebellar Ataxia Type 17 (SCA17).
Toyoshima Y; Takahashi H
Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
[TBL] [Abstract][Full Text] [Related]
8. CAG RNAs induce DNA damage and apoptosis by silencing
Peng S; Guo P; Lin X; An Y; Sze KH; Lau MHY; Chen ZS; Wang Q; Li W; Sun JK; Ma SY; Chan TF; Lau KF; Ngo JCK; Kwan KM; Wong CH; Lam SL; Zimmerman SC; Tuccinardi T; Zuo Z; Au-Yeung HY; Chow HM; Chan HYE
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947817
[TBL] [Abstract][Full Text] [Related]
9. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
Zhang X; Abels ER; Redzic JS; Margulis J; Finkbeiner S; Breakefield XO
Cell Mol Neurobiol; 2016 Apr; 36(3):459-70. PubMed ID: 26951563
[TBL] [Abstract][Full Text] [Related]
10. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
Huang S; Yang S; Guo J; Yan S; Gaertig MA; Li S; Li XJ
Cell Rep; 2015 Oct; 13(1):196-208. PubMed ID: 26387956
[TBL] [Abstract][Full Text] [Related]
11. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17.
Gao R; Matsuura T; Coolbaugh M; Zühlke C; Nakamura K; Rasmussen A; Siciliano MJ; Ashizawa T; Lin X
Eur J Hum Genet; 2008 Feb; 16(2):215-22. PubMed ID: 18043721
[TBL] [Abstract][Full Text] [Related]
12. Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
Zhang Q; Tsoi H; Peng S; Li PP; Lau KF; Rudnicki DD; Ngo JC; Chan HY
Dis Model Mech; 2016 Mar; 9(3):321-34. PubMed ID: 26839389
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of RNA-induced toxicity in CAG repeat disorders.
Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S
Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
Bech S; Petersen T; Nørremølle A; Gjedde A; Ehlers L; Eiberg H; Hjermind LE; Hasholt L; Lundorf E; Nielsen JE
Parkinsonism Relat Disord; 2010 Jan; 16(1):12-5. PubMed ID: 19595623
[TBL] [Abstract][Full Text] [Related]
15. The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice.
Chen CM; Chen WL; Hung CT; Lin TH; Chao CY; Lin CH; Wu YR; Chang KH; Yao CF; Lee-Chen GJ; Su MT; Hsieh-Li HM
Neurotoxicology; 2018 Jul; 67():259-269. PubMed ID: 29936316
[TBL] [Abstract][Full Text] [Related]
16. Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar Ataxia 17.
Roshan R; Ghosh T; Gadgil M; Pillai B
RNA Biol; 2012 Jun; 9(6):891-9. PubMed ID: 22664922
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
18. TATA-binding protein in neurodegenerative disease.
van Roon-Mom WM; Reid SJ; Faull RL; Snell RG
Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858
[TBL] [Abstract][Full Text] [Related]
19. Molecular investigation of TBP allele length: a SCA17 cellular model and population study.
Reid SJ; Rees MI; van Roon-Mom WM; Jones AL; MacDonald ME; Sutherland G; During MJ; Faull RL; Owen MJ; Dragunow M; Snell RG
Neurobiol Dis; 2003 Jun; 13(1):37-45. PubMed ID: 12758065
[TBL] [Abstract][Full Text] [Related]
20. Deactivation of TBP contributes to SCA17 pathogenesis.
Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
